- Home
- KNSA vs USAS Comparison
KNSA vs USAS Comparison
Compare KNSA & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | USAS |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 1.9B |
| IPO Year | 2018 | 2004 |
Fundamental Metrics
Financial Performance| Metric | KNSA | USAS |
|---|---|---|
| Price | $52.46 | $5.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $58.43 | $6.50 |
| AVG Volume (30 Days) | 742.4K | ★ 4.7M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $174.68 |
| Revenue Next Year | $17.87 | $53.17 |
| P/E Ratio | $71.19 | ★ N/A |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $25.71 | $0.55 |
| 52 Week High | $54.23 | $10.50 |
Technical Indicators
Market Signals| Indicator | KNSA | USAS |
|---|---|---|
| Relative Strength Index (RSI) | 66.79 | 40.68 |
| Support Level | $40.67 | $4.71 |
| Resistance Level | N/A | $6.24 |
| Average True Range (ATR) | 2.20 | 0.37 |
| MACD | 0.68 | 0.02 |
| Stochastic Oscillator | 85.60 | 6.31 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.